Multiple sclerosis (MS) is a complex and disabling chronic nervous system disease.This disease acute active central nervous white matter has multiple inflammatory demyelinating spots, old lesions due to glial fiber hyperplasia and calcification spots, with multiple lesions, remission, recurrence of the course of disease as the characteristics, multiple sclerosis drug treatment can reduce the recurrence rate of this disease and slow down the process of disability.
This report contains market size and forecasts of Multiple Sclerosis Drugs Treatment in Global, including the following market information:
Global Multiple Sclerosis Drugs Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Multiple Sclerosis Drugs Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Interferon Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Multiple Sclerosis Drugs Treatment include Pfizer, Roche, Biogen, Teva Pharmaceutical, Merck, Novartis, Bayer, Sanofi and Acorda Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiple Sclerosis Drugs Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiple Sclerosis Drugs Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Multiple Sclerosis Drugs Treatment Market Segment Percentages, by Type, 2021 (%)
Interferon
Immunomodulator
Immunosuppressant
Global Multiple Sclerosis Drugs Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Multiple Sclerosis Drugs Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other
Global Multiple Sclerosis Drugs Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Multiple Sclerosis Drugs Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiple Sclerosis Drugs Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Multiple Sclerosis Drugs Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Biogen
Teva Pharmaceutical
Merck
Novartis
Bayer
Sanofi
Acorda Therapeutics
Questcor Pharmaceuticals
AbbVie
Opexa Therapeutics
Genzyme Corporation